The Patterns of Antipsychotic Use for Pregnant Women Over a 16-year Timeframe in an Australian Principal Referral and Specialist Women and Newborn Hospital

被引:0
作者
Stephanie W. K. Teoh
Tamara Lebedevs
Thinh Nguyen
Jacqueline Frayne
Karen Donn
机构
[1] King Edward Memorial Hospital,The Pharmacy Department
[2] University of Western Australia Medical School,Discipline of Psychiatry
[3] Kwinana Mental Health Service,Peel and Rockingham
[4] Childbirth and Mental Illness Clinic,Discipline of General Practice
[5] King Edward Memorial Hospital,undefined
[6] University of Western Australia,undefined
来源
Psychiatric Quarterly | 2023年 / 94卷
关键词
Medication; Antipsychotic; Dispensing; Pregnancy;
D O I
暂无
中图分类号
学科分类号
摘要
The purpose of the study is to analyse the patterns of antipsychotic use for pregnant women in an Australian Principal Referral and Specialist Women and Newborn Hospital. This retrospective, observational study involved an analysis of dispensing data of antipsychotics from 1998 to 2014 extracted from the pharmacy dispensing systems. The study included 282 antipsychotic dispensings in the years 1999 to 2006 and 3041 dispensings in the years 2007 to 2014. Second-generation antipsychotic use during pregnancy increased over time, while first-generation-antipsychotics showed declining trend. The use of quetiapine has increased from 2.9% of total antipsychotic dispensings in 2002 up to 77.9% of total antipsychotic dispensings in 2008. Olanzapine use decreased from 78.1% in 2003 to around 20% since 2006. When comparing the age distribution, there was an increased proportion of patients receiving antipsychotics in the 30–39 age range in the second period of 2007 to 2014 compared to 1999 to 2006. The proportion of women on more than one antipsychotic increased from 5% (n = 8) to 9.8% (n = 81) when comparing between 1999 and 2006 and between 2007 and 2014. Our findings indicate a significant shift in prescribing patterns over the study period, with the increased use of antipsychotics, particularly the emergence of SGAs from 2007, changing trends in the use of specific medications as published findings on their safety profiles becomes evident, and more polypharmacy prescribing.
引用
收藏
页码:23 / 32
页数:9
相关论文
共 64 条
[1]  
Jablensky AV(2005)Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders Am J Psychiatry 162 79-91
[2]  
Morgan V(2014)Adverse obstetric and neonatal outcomes in women with severe mental illness: to what extent can they be prevented? Schizophr Res 157 305-309
[3]  
Zubrick SR(2007)Maternal mortality and psychiatric morbidity in the perinatal period: challenges and opportunities for prevention in the Australian setting Med J Aust 186 364-367
[4]  
Bower C(2019)Obstetric outcomes for women with severe mental illness: 10 years of experience in a tertiary multidisciplinary antenatal clinic Arch Gynecol Obstet 300 889-896
[5]  
Yellachich LA(2013)Obstetric and neonatal outcomes of pregnant women with severe mental illness at a specialist antenatal clinic Med J Aust 199 S26-S29
[6]  
Judd F(2011)A review of the use of psychotropic medication in pregnancy Curr Opin Obstet Gynecol 23 408-414
[7]  
Komiti A(2020)Antipsychotic drug use in pregnancy: A multinational study from ten countries Schizophr Res 220 106-115
[8]  
Sheehan P(2013)Increasing use of atypical antipsychotics and anticonvulsants during pregnancy Pharmacoepidemiol Drug Saf 22 794-801
[9]  
Newman L(2017)Antipsychotic Medication Use Among Publicly Insured Pregnant Women in the United States Psychiatr Serv 68 1112-1119
[10]  
Castle D(2022)Psychotropic drug utilization patterns in pregnant women with bipolar disorder: A 16-year population-based cohort study Eur Neuropsychopharmacol 57 75-85